Valeo Pharma Inc. (VPHIF)

Valeo Pharma Revenue

Valeo Pharma had revenue of 12.60M CAD in the quarter ending July 31, 2024, a decrease of -10.52%. This brings the company's revenue in the last twelve months to 53.38M, down -0.16% year-over-year. In the fiscal year ending October 31, 2023, Valeo Pharma had annual revenue of 53.91M with 94.31% growth.

• Revenue (ttm): 53.38M CAD
• Revenue Growth: -0.16%
• P/S Ratio: n/a
• Revenue / Employee: 762.53K CAD
• Employees: 70
• Market Cap: 99.00 USD

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Oct 31, 2023	53.91M	26.17M	94.31%
Oct 31, 2022	27.75M	14.19M	104.65%
Oct 31, 2021	13.56M	6.09M	81.49%
Oct 31, 2020	7.47M	893.00K	13.58%
Oct 31, 2019	6.58M	2.20M	50.09%